Our results align with previous findings from the previous mouse model, where the frequency of TIGIT+ CD8+ T cells was positively correlated with tumor burden, while the frequency of CD226+ CD8+ T cells showed a negative correlation [48]. This evidence concerns the gene CD226 and neoplasm.